On May 30, 2019 ImaginAb, Inc., a clinical stage immuno-oncology imaging company, reported that it is scheduled to present at the following investor and scientific conferences in May and June 2019 (Press release, ImaginAb, MAY 30, 2019, View Source [SID1234536679]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
US-China Bio-Partnering Forum
May 30-31 2019, Chicago, Illinois
Ian Wilson CEO will update investors on current progress of ImaginAb programs and pharmaceutical collaborations.
2019 ASCO (Free ASCO Whitepaper) Annual Meeting
May 31-June 4, 2019, McCormick Place, Chicago, Illinois
Ian Wilson, CEO, Ivan Plavec, CBO, and Ron Korn CMO, will be attending and hosting meetings.
2019 BIO International Convention
June 3-6, 2019, Pennsylvania Convention Center, Philadelphia, Pennsylvania
Ivan Plavec, CBO, will be attending and hosting meetings.
Cavendish Global Conference
June 18-19, 2019, Chicago, Illinois
Ian Wilson CEO will update the conference on current progress of ImaginAb programs and pharmaceutical collaborations.
SNMMI 2019 Annual Meeting
June 22-25, 2019, Anaheim Convention Center, Anaheim, California
ImaginAb will have a booth at the SNMMI conference, where ImaginAb team will be hosting meetings, with clinical investigators, pharmaceutical companies, and partner organizations.
Ian Wilson CEO will update the conference on ImaginAb’s lead program 89ZrCD8PET on Sunday, June 23 in 6.23 CMIT in the Emerging Technologies session.
Inquiries or to schedule a meeting:
ImaginAb
Ian Wilson, Salli Walker
Email: [email protected]
Phone: +1 310 645 1211
Optimum Strategic Communications
Mary Clark, Supriya Mathur, Manel Mateus
Email: [email protected]
Phone: +44 20 3950 9144